Insights into the mechanism of haemorrhage caused by snake venom metalloproteinases

Toxicon

Volumn 34, Issue 6, 1996, Pages 627-642

  Kamiguti, Aura S ^a   Hay, Charles R M ^a   Theakston, R David G ^b   Zuzel, Mirko ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOPROTEINASE; SNAKE VENOM; VIPER VENOM;

ARTICLE; BLEEDING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

BOTHROPS JARARACA; CROTALINAE; SERPENTES; VIPER;

EID: 0030175550     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/0041-0101(96)00017-7     Document Type: Review

References (96)

1. 1 functions as a sperm receptor. Cell 81, 1095-1104.
2. 1-Antitrypsin. Meth. Enzymol. 163, 400-418.
3. Assakura, M. T., Salomao, M. G., Puorto, G. and Mandelbaum, F. R. (1992) Hemorrhagic, fibrinogenolytic and edema-forming activities of the venom of the colubrid Philodryas olfersii (green snake). Toxicon 30, 427-437.
4. Baramova, E. N., Shannon, J. D., Bjarnason, J. B. and Fox, J. W. (1989) Degradation of extracellular matrix proteins by haemorrhagic metalloproteinases. Archs Biochem. Biophys. 275, 63-71.
5. 2-macroglobulin. Biochemistry 29, 1069-1074.
6. 2-macroglobulin with proteinases. Biochem. J. 133, 709-724.
7. 2-macroglobulin molecule. Biochem. J. 181, 401-418.
8. Baumgartner, H. R., Tschoop, T. B. and Weiss, H. J. (1978) Defective adhesion of platelets to subendothelium in von Willebrand's disease and Bernard Soulier Syndrome. Thromb. Haemostas. 39, 782-783.
9. Berkowitz, S. D., Dent, J., Roberts, J., Fujimura, Y., Plow, E. P., Titani, K., Rugeri, Z. M. and Zimmerman, T. S. (1987) Epitope mapping of the von Willebrand factor subunit distinguishes fragments present in normal and type IIA von Willebrand disease from those generated by plasmin. J. clin. Invest. 79, 524-531.
10. Bithell, T. C. (1993). The physiology of primary haemostasis. In: Wintrobe's Clinical Hematology, pp. 540-565 (Lee, J. R., Bithell, T. C., Foester, J., Athens, J. W. and Lukens, J. N., Eds.). London: Lea and Febiger.
11. Bjarnason, J. B. and Fox, J. W. (1988/89). Hemorrhagic toxins from snake venoms. J. Toxicol. - Toxins Rev. 7, 121-209.
12. Bjarnason, J. B. and Fox, J. W. (1994) Hemorrhagic metalloproteinases from snake venoms. Pharmac. Ther. 62, 325-372.
13. Bjarnason, J. B. and Tu, A. T. (1978) Hemorrhagic toxins from Western diamondback rattlesnake (Crotalus atrox) venom: isolation and characterization of five toxins and the role of zinc in hemorrhagic toxin e. Biochemistry 17, 3395-3404.
14. Bjarnason, J. B., Hamilton, D. and Fox, J. W. (1988) Studies on the mechanism of hemorrhage production by five proteolytic toxins from Crotalus atrox venom. Biol. Chem. Hoppe-Seyler 369, 121-129.
15. Blobel, C. P., Wolfsberg, T. G., Turck, C. W., Myles, D. G., Primakoff, C. W. and White, J. M. (1992) A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature 356, 248-252.
16. Blomback, B. and Vestermark, A. (1958) Isolation of fibrinopeptides by chromatography. Arkir Kemi 12, 173-182.
17. Blomback, B., Hessel, B., Hogg, D. and Therkildsen, L. (1978) A two-step fibrinogen fibrin transition in blood coagulation. Nature 275, 501-505.
18. Calvete, J. J., Mann, K., Alvarez, M. V., Lopez, M. M. and Rodriguez, J. G. (1992) Proteolytic dissection of the isolated platelet fibrinogen receptor, integrin gpIIb/IIIa. Biochem. J. 282, 523-532.
19. Cardoso, J. L. C., Fan, H. W., Franca, F. O. S., Jorge, M. T., Leite, R. P., Nishioka, S. A., Avila, A.. Sano-Martins, I. S., Santoro, M. L., Chudzinski, A. M., Castro, S. C. B., Kamiguti, A. S., Kelen, E. M. A., Hirata, M. H., Mirandola. R. M. S., Theakston, R. D. G. and Warrell, D. A. (1993) Randomized comparative trial of three antivenoms in the treatment of envenoming by lance-headed vipers (Bothrops jararaca) in Sao Paulo, Brazil. Q. J. Med. 86, 315-325.
20. Cooper, H. A., Bennett, W. P., White, G. C. and Wagner, R. H. (1982) Hydrolysis of human platelet membrane glycoproteins with a Serratia marscescens metalloproteinase: effect on response to thrombin and von Willebrand factor. Proc. natn. Acad. Sci. U.S.A. 79, 1433-1437.
21. Doolittle, R. F. (1984) Fibrinogen and fibrin. Ann. Rev. Biochem. 53, 195-229.
22. Dong, Z., Thoma, R. S., Crimmins, D. L., McCourt, D. W., Tuley, E. A. and Sadler, J. E. (1994) Disulfide bonds required to assemble functional von Willebrand factor multimers. J. biol. Chem. 269, 6753-6758.
23. Gan, Z. R., Gould, R. J., Jacobs, J. W., Friedman, P. A. and Polokoff, M. A. (1988) A potent aggregation inhibitor from the venom of the viper Echis carinatus. J. biol. Chem. 263, 19827-19832.
24. Gitter, S. and de Vries, A. (1968). Symptomatology, pathology and treatment of bites by Near Eastern, European and North African snakes. In: Venomous Animals and their Venoms, pp. 359-401 (Bucherl, W., Buckley, E. E. and Deulofeu, V., Eds). New York: Academic Press.
25. Hawiger, J., Timmons, S., Kloczewiak, M., Strong, D. D. and Doolittle, R. F. (1982) γ and α chains of human fibrinogen possess sites reactive with human platelet receptors. Proc. natn. Acad. Sci. U.S.A. 79, 2068-2071.
26. Hawiger, J., Kloczewiak, M.. Bednarek, M. A. and Timmons, S. (1989) Platelet receptor recognition domains on the alpha chain of human fibrinogen: structure-function analysis. Biochemistry 28, 2909-2914.
27. Hite, L. A., Shannon, J. D., Bjarnason, J. B. and Fox, J. W. (1992) Sequence of a cDNA clone encoding the zinc metalloproteinase hemorrhagic toxin e from Crotalus atrox: evidence for signal, zymogen, and disintegrin-like structures. Biochemistry 31, 6203-6211.
28. Huang, T.-F., Holt, J. C., Lukasiewcz, H. and Niewiarowski, S. (1987) Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb/IIIa complex. J. biol. Chem. 262, 16157-16163.
29. Hutton, R. A. and Warrell, D. A. (1993) Action of snake venom components on the haemostatic system. Blood Rev. 7, 176-189.
30. Iwanaga, S. and Suzuki, T. (1979) Enzymes in snake venoms. Hand. Exp. Pharmacol. 52, 61-158.
31. 1 (VLA-2, CD49b/29). J. biol. Chem. 269, 9659-9663.
32. Kamiguti, A. S. and Sano-Martins, I. S. (1995) South American snake venoms affecting haemostasis. J. Toxinol.-Toxin Rev. 14, 359-374.
33. Kamiguti, A. S., Rugman, F. P., Theakston, R. D. G., Franca, F. O. S., Ishii, H., Hay, C. R. M. and BIASG. (1992) The role of venom haemorrhagin in spontaneous bleeding in Bothrops jararaca envenoming. Thromb. Haemostas. 67, 484-488.
34. Kamiguti, A. S., Theakston, R. D. G., Desmond, H. P. and Hutton, R. A. (1991) Systemic haemorrhage in rats induced by a haemorrhagic fraction from Bothrops jararaca venom. Toxicon 29, 1097-1105.
35. Kamiguti, A. S., Cardoso, J. L. C., Theakston, R. D. G., Sano-Martins, I. S., Hutton, R. A., Rugman, F. P., Warrell, D. A. and Hay, C. R. M. (1991) Coagulopathy and haemorrhage in human victims of Bothrops envenoming in Brazil. Toxicon 29, 961-972.
36. 1 integrin (gpIa/IIa) by jararhagin, a haemorrhagic metalloproteinase from Bothrops jararaca venom. Br. J. Haematol. 89, 8.
37. Kamiguti, A. S., Hay, C. R. M, and Zuzel, M. (1995) Cleavage of von Willebrand factor by jararhagin, a haemorrhagic metalloproteinase from Bothrops jararaca venom. (Abstr).. Toxicon 33, 260.
38. 2-macroglobulin. Biochim. biophys. Acta 1200, 307-314.
39. Kamiguti, A. S., Slupsky, J. R., Zuzel, M. and Hay, C. R. M. (1994) Properties of fibrinogen cleaved by jararhagin, a metalloproteinase from the venom of Bothrops jararaca. Thromb. Haemostas. 72, 244-249.
40. Kini, R. and Evans, H. J. (1991) Inhibition of platelet aggregation by a fibrinogenase from Naja nigricollis is independent of fibrinogen degradation. Biochim. biophys. Acta 1095, 117-121.
41. Kini, R. and Evans, H. J. (1992) Structural domains in venom proteins: evidence that metalloproteinases and nonenzymatic platelet aggregation inhibitors (disintegrins) from snake venoms are derived by proteolysis from a common precursor. Toxicon 30, 265-293.
42. Kloczewiak, M., Timmons, S., Lucas, T. J. and Hawiger, J. (1984) Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the γ chain. Biochemistry 23, 1767-1774.
43. Koopman, J., Haverkate, F., Grimbergen, J., Egbring, R. and Lord, S. T. (1992) Fibrinogen Marburg: a homologous case of dysfibrinogenemia, lacking amino acids Aα461-610 (Lys461 AAA → Stop TAA). Blood 80, 1972-1979.
44. Kornalik, F. (1992). Analysis of haemorrhagic diathesis (HD) and DIC due to snake venom enzymes on an experimental model. In: Recent Advances in Venom Research, pp. 500-506 (Gopalakrishnakone, P and Tan, C. K., Eds). Singapore: National University of Singapore.
45. Kouyoumdjian, J. A., Polizelli, C., Lobo, S. M. A. and Guimaraes, S. M. (1991) Fatal extradural haematoma after snake bite (Bothrops moojeni). Trans. R. Soc. trop. Med. Hyg. 85, 552.
46. 2 macroglobulin on the proteolytic activity of snake venoms. Toxicon 19, 501-507.
47. Kudryk, B., Collen, D., Woods, K. R. and Blomback, B. (1974) Evidence for localization of polymerization sites in fibrinogen. J. biol. Chem. 249, 3322-3325.
48. Kudryk, B., Reuterby, J. and Blomback, B. (1973) Adsorption of plasmic fragment D to thrombin modified fibrinogen-Sepharose. Thromb. Res. 2, 297-304.
49. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
50. Lomonte, B. (1994). Tissue damage and inflammation induced by snake venoms. Goteborg: Ph.D. Thesis.
51. Markland, F. S. (1991) Inventory of α-and ß-fibrinogenase from snake venoms. Thromb. Haemostas. 65, 438-443.
52. Maruyama, M., Kamiguti, A. S., Cardoso, J. L. C., Sano-Martins, I. S., Chudzinski, A. M., Santoro, M. L., Morena, P., Antonio, L. C., Mihara, M. and Kelen, E. M. A. (1990) Studies on blood coagulation and fibrinolysis in patients bitten by Bothrops jararaca (Jararaca). Thromb. Haemostas. 63, 449-453.
53. Maruyama, M., Sugiki, M., Yoshida, E., Shimaya, K. and Mihara, H. (1992) Broad substrate specificity of snake venom fibrinolytic enzymes: possible role in haemorrhage. Toxicon 30, 1387-1397.
54. McKeown, L., Vail, M., Williams, S., Kramer, W., Hansmann, K. and Gralnick, H. (1994) Platelet adhesion to collagen in individuals lacking glycoprotein IV. Blood 83, 2866-2871.
55. Neeper, M. P. and Jacobson, M. A. (1990) Sequence of a cDNA encoding a platelet-aggregation inhibitor Trigramin. Nucl. Acid Res. 18, 4255-4261.
56. Nieuwenhuis, H. K., Akkerman, J. W. M., Houdijk, W. P. M. and Sixma, J. J. (1985) Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 318, 470-472.
57. Nishida, S., Fujita, T., Atoda, H., Morita, T., Takeya, H., Kido, I., Paine, M. J. I., Kawabata, S. and Iwanaga, S. (1995) cDNA cloning and deduced amino acid sequence of prothrombin activator (Ecarin) from Kenyan Echis carinatus venom. Biochemistry 34, 1771-1778.
58. Obrig, T. G., Louise, C. B., Moran, T. P., Mori, N. and Tu, A. T. (1993) Direct cytotoxic effects of hemorrhagic toxins from Crotalus ruber ruber and Crotalus atrox on human vascular endothelial cells, in vitro. Microvasc. Res. 46, 412-416.
59. Ohsaka, A. (1979) Hemorrhagic, necrotizing and edema-forming effects of snake venoms. Hand. Exp. Pharmac. 52, 480-546.
60. Ohsaka, A., Just, M. and Habermann, E. (1973) Action of snake venom principles on isolated glomerular basement membrane. Biochim. biophys. Acta 323, 415-428.
61. Olexa, S. A. and Budzynski, A. Z. (1980) Evidence for four different polymerization sites involved in fibrin formation. Proc. natn. Acad. Sci. U.S.A. 77, 1374-1378.
62. Ouyang, C., Teng, C.-M. and Chen, Y. C. (1979) Properties of fibrinogen degradation products produced by α-and ß-fibrinogenases of Trimeresurus mucrosquamatus snake venom. Toxicon 17, 121-126.
63. Ouyang, C., Teng, C.-M. and Huang, T.-F. (1987) Characterization of snake venom principles affecting blood coagulation and platelet function. Asia Pacific J. Pharmacol. 2, 169-179.
64. Ouyang, C., Teng, C.-M. and Huang, T.-F. (1992) Characterization of snake venom components acting on blood coagulation and platelet function. Toxicon 30, 945-966.
65. Ownby, C. L. (1990). Locally acting agents: myotoxins, hemorrhagic toxins and dermonecrotic factors. In: Handbook of Toxinology, pp. 602-654 (W. T. Shier and D. Mebs, Ed). New York, Marcel Dekker.
66. Paine, M., Desmond, H. P., Theakston, R. D. G. and Crampton, J. M. (1992) Purification, cloning and molecular characterization of a high molecular weight hemorrhagic metalloproteinase, jararhagin, from Bothrops jararaca venom. J. biol. Chem. 267, 22869-22876.
67. Paine, M. J. I., Moura-da-Silva, A. M., Theakston, R. D. G. and Crampton, J. M. (1994) Cloning of metalloprotease genes in the carpet viper (Echis pyramidum leakyi). Further members of the metalloprotease/disintegrin gene family. Eur. J. Biochem. 224, 483-488.
68. Pandya, B. V. and Budzynski, A. Z. (1984) Anticoagulant proteases from Western diamondback rattlesnake (Crotalus atrox) venom. Biochemistry 23, 460-467.
69. Peerschke, E. I. and Galakanis, D. K. (1983) Binding of fibrinogen to ADP-treated platelets. Comparison of plasma fibrinogen fractions and early plasmic degradation derivatives. J. Lab. Clin. Med. 101, 453-460.
70. Plow, E. F., Srouji, A. H., Meyer, D., Marguerie, G. and Ginsberg, M. H. (1984) Evidence that three adhesive proteins interact with a common recognition site on activated platelets. J. biol. Chem. 259, 5388-5391.
71. Rosenfeld, G. (1971). Symptomatology, pathology and treatment of snake bites in South America. In: Venomous Animals and their Venoms, pp. 345-384 (Bücherl, W., Buckley, E. and Deulofeu, V., Eds). New York: Academic Press.
72. Ruggeri, Z. M. and Ware, J. (1992) The structure and function of von Willebrand factor. Thromb. Haemostas. 67, 594-599.
73. Santoro, S. A. (1986) Identification of a 160,000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen. Cell 46, 913-920.
74. Santoro, S. A., Rajpara, S. M., Staatz, W. D. and Woods, V. L. (1988) Isolation and characterization of a platelet surface collagen binding complex to VLA-2. Biochem. biophys. Res. Commun. 153, 217-223.
75. Scarborough, R. M., Rose, J. W., Naughton, M. A., Phillips, D. R., Nannizzi, L., Arfsten, A., Campbell, A. M. and Charo, I. F. (1993) Characterization of the integrin specificities of disintegrins isolated from American pit vipers venoms. J. biol. Chem. 268, 1058-1065.
76. Seegers, W. H. and Ouyang, C. (1979) Snake venoms and blood coagulation. Hand. Exp. Pharmacol. 52, 684-750.
77. Shapira, M., Agostini, A. and Colman, R. W. (1988) C1 Inhibitor: the predominant inhibitor of plasma kallikrein. Meth. Enzymol. 163, 179-185.
78. Silva, M. V. and Buononato, M. A. (1983/84). Relato clinico de envenenamento humano por Philodryas olfersii. Mem. Inst. Butantan 47/48, 121-126.
79. 2-macroglobulin-proteinase complexes. J. biol. Chem. 265, 17727-17737.
80. 2-macroglobulin cleaved during proteinase complex formation. FEBS Lett. 121, 275-279.
81. 2-macroglobulin. Nature of the complex. FEBS Lett. 127, 167-173.
82. + +-dependent adhesion of platelets to collagen. J. Cell Biol. 108, 1917-1924.
83. Takeya, H.. Nishida, S., Nishino, N., Makinose. Y.. Omori-Satoh, T.. Nikai, T., Sugihara, H. and Iwanaga, S. (1993) Primary structures of platelet aggregation inhibitors (disintegrins) autoproteolytically released from snake venom hemorrhagic metalloproteinases and new fluorgenic peptide substrates for these enzymes. J. Biochem. 113, 473-483.
84. Takeya, H., Nishida, S., Miyata, T., Kawada, S., Saisaka, Y., Morita, T. and Iwanaga, S. (1992) Coagulation factor X activating enzyme from Russell's viper venom (RVV-X). J. biol. Chem. 267, 14109-14117.
85. Takeya. H., Oda, K., Miyata, T., Omori-Satoh, T. and Iwanaga, S. (1990) The complete amino acid sequence of high molecular mass hemorrhagic protein HR1B isolated from the venom of Trimeresurus flavoviridis. J. biol. Chem. 265, 16068-16073.
86. Talle, M. A., Rao, P. E.. Westberg, E.. Allegar, N., Makowski, M., Mittler, R. S. and Goldstein, G. (1983) Patterns of antigenic expression on human monocytes as defined by monoclonal antidbodies. Cell Immunol. 78, 83-87.
87. Teng, C.-M. and Huang, T.-F. (1991) Inventory of exogenous inhibitors of platelet aggregation. Thromb. Haemostas. 65, 624-626.
88. Theakston. R. D. G. and Reid, H. A. (1983) The development of simple standard assay procedures for the characterization of snake venoms. Bull. WHO 61, 949-956.
89. Titani, K.. Kumar, S., Takio, K., Ericsson, L. H., Wade. R. D., Ashida. K., Walsh, K. A., Chopek, M. W.. Sadler, J. E. and Fujiwara, K. (1986) Amino acid sequence of human von Willebrand factor. Biochemistry 25, 3171-3184.
90. Usami, Y., Fujimura, Y., Miura, S., Shima, H., Yoshida, E., Yoshioka, A., Hirano, K., Suzuki, M. and Titani, K. (1994) A 28 kDa-protein with disintegrin-like structure (jararhagin-C) purified from Bothrops jararaca venom inhibits collagen-and ADP-induced platelet aggregation. Biochem. biophys. Res. Commun. 201, 331-339.
91. Warrell, D. A., Ormerod, L. D. and Davidson, N. McD. (1975) Bites by puff-adder (Bitis arietans) in Nigeria, and value of antivenom. Br. Med. J. 20, 697-700.
92. Warrell, D. A., Davidson, N. McD., Greenwood, B. M.. Ormerod, L. D. and Prentice, C. R. M. (1977) Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria. Q. J. Med. 46, 33-62.
93. Weiss, H. J., Turitto, V. T. and Baumgartner, H. R. (1986) Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa and Ib and storage α-granules. Blood 67, 322-330.
94. Wicki. A. N. and Clemetson, K. J. (1985) Structure and function of platelet membrane glycoproteins Ib and V. Effects of leukocyte elastase and other proteases on platelets response to von Willebrand factor and thrombin. Eur. J. Biochem. 153, 1-11.
95. Wilman, B. and Collen, D. (1978) On the kinetics of the reaction between human antiplasmin and plasmin. Eur. J. Biochem. 84, 573-578.
96. Zimmerman, T. S., Dent, J. A., Ruggeri, Z. M. and Nannini, L. H. (1986) Subunit composition of plasma von Willebrand factor. J. clin. Invest. 77, 947-951.